LAB
Standard Biotools Inc
NASDAQ: LAB · HEALTHCARE · MEDICAL DEVICES
$0.93
+4.69% today
Updated 2026-04-30
Market cap
$350.48M
P/E ratio
—
P/S ratio
4.11x
EPS (TTM)
$-0.15
Dividend yield
—
52W range
$1 – $2
Volume
2.7M
Standard Biotools Inc (LAB) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-22.31M | $-21.76M | $-28.72M | $-19.51M | $-11.51M | $-17.54M | $-17.48M | $-1.59M | $-22.62M | $-34.70M | $-39.10M | $-24.10M | $-25.20M | $-35.21M | $-15.42M | $-44.06M | $-89.37M | $-43.29M | $-143.45M | $-74.35M |
| Capital expenditures | $2.93M | $973000.00 | $910000.00 | $799000.00 | $1.54M | $1.68M | $2.38M | $4.69M | $7.40M | $10.65M | $5.07M | $1.62M | $372000.00 | $2.53M | $12.72M | $13.26M | $3.83M | $2.83M | $8.36M | $8.30M |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $145000.00 | $708000.00 | $2.02M | $2.11M | $1.59M | $2.80M | $4.09M | $6.44M | $20.94M | $16.83M | $13.86M | $9.09M | $11.02M | $11.39M | $14.45M | $16.10M | $14.88M | $13.12M | $31.73M | $29.61M |
| Free cash flow | $-25.24M | $-22.73M | $-29.63M | $-20.31M | $-13.05M | $-19.22M | $-19.86M | $-6.28M | $-30.03M | $-45.35M | $-44.16M | $-25.71M | $-25.57M | $-37.74M | $-28.13M | $-57.33M | $-93.19M | $-46.12M | $-151.81M | $-82.65M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | — | — | — | $1.50M | — | $299000.00 | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | $53.26M | — | — | — |